AbCellera Biologics Inc. (ABCL)

NASDAQ: ABCL · Real-Time Price · USD

4.270

-0.250 (-5.53%)

At close: Jan 13, 2026, 4:00 PM EST

4.300

+0.030 (0.70%)

After-hours: Jan 13, 2026, 5:44 PM EST

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2016 - 2019
Antibodies	28.83M	Log In	Log In	Log In	Log In	Upgrade
Antibodies Growth	-24.17%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2016 - 2019
Canada	26.20M	Log In	Log In	Log In	Log In	Upgrade
Canada Growth	-27.22%	Log In	Log In	Log In	Log In	Upgrade
United States	2.70M	Log In	Log In	Log In	Log In	Upgrade
United States Growth	35.00%	Log In	Log In	Log In	Log In	Upgrade